Top Ad
Bicalutamide

Bicalutamide

Form: Tablets

Strength: 50 mg , 150 mg

Reference Brands: Casodex®(US & EU)

Category: Oncology Cancer Care

Bicalutamide Tablets, available in 50 mg and 150 mg strengths, are widely used in the treatment of prostate cancer in both the US and EU. As a non-steroidal anti-androgen, Bicalutamide inhibits androgen receptors to block testosterone-driven cancer growth, making it an essential part of combination therapy with LHRH analogs or as monotherapy. Marketed under brands like Casodex®, it is a globally trusted oncology drug. Bicalutamide is manufactured under GMP conditions, ideal for B2B pharmaceutical sourcing, contract manufacturing, and global distribution. Its high stability and oral dosage form make it a preferred API for regulated markets. ? Short Description

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Atezolizumab

Strength: 1200 mg/20 mL

Form: Intravenous infusion

Reference Brands: Tecentriq® (EU & US)

View Details Get Enquiry
Durvalumab

Strength: 120 mg/4 mL, 500 mg/10 mL

Form: Injection

Reference Brands: Imfinzi® (US & EU)

View Details Get Enquiry
Sunitinib

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg

Form: Tablet

Reference Brands: Sutent® (EU & US)

View Details Get Enquiry
Ifosfamide

Strength: 1 g/vial,2 g/vial, 3 g/vial

Form: Injection

Reference Brands: Ifex® (US), Holoxan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.